GSK plc has grown revenue 3.7% a year over three years and 6.0% a year over five, with earnings per share compounding at −28%. Revenue growth, 3-year annual rate: +3.7% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +6.0%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −28%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 11, FY2015 to FY2025, as filed.

GSKGSK plc

Healthcare

$46.51+17% 1Y

$46.51

$38.5152 weeks$60.14

Is it growing?

Good

Growing: earnings up +123% year on year and operating margin widening (+6.6 points).

2 good, 1 neutral

Revenue trend+4% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +6% a year.

Earnings trend+123% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+6.6 points operating

Trailing-twelve-month operating margin, 24.3% now against 17.6% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is GSK growing?

GSK plc has grown revenue 3.7% a year over three years and 6.0% a year over five, with earnings per share compounding at −28%.

+3.7%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · growing slowly · compounded from fiscal years as filed

Revenue growth, 5-year rate: +6.0%
Revenue growth, 5-year rate · +3.7% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −28%
Earnings per share, 3-year rate · revenue +3.7% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed